Skip to main content
. 2014 Apr 23;2014:640909. doi: 10.1155/2014/640909

Table 1.

Comparisons between patients with different level of 25-(OH)D.

All patients 25-(OH)D < 50 nmol/L 25-(OH)D ≥ 50 nmol/L P value
Number of patients 1408 1097 311
Gender (male/female) 57.4%/42.6% 59.6%/40.4% 65.9%/34.1% 0.09
Age (years) 57.1 ± 13.54 57.5 ± 12.9 57.0 ± 12.5 0.63
Duration of DM (years) 9.4 ± 7.7 9.4 ± 7.8 10.1 ± 7.4 0.29
BMI (kg/m2) 25.24 ± 4.00 25.38 ± 3.80 25.27 ± 3.44 0.72
Waist (cm) 91.9 ± 12.1 92.1 ± 11.6 90.9 ± 13.6 0.24
SBP (mmHg) 131.7 ± 17.3 131.1 ± 17.4 132.3 ± 15.2 0.59
DBP (mmHg) 78.8 ± 11.2 78.7 ± 11.4 80.2 ± 10.48 0.13
25-(OH)D (nmol/L) 35.72 ± 13.64 32.41 ± 8.02 60.22 ± 11.20 0.00
HbA1c (%) 8.95 ± 2.11 9.03 ± 2.10 8.55 ± 2.05 0.01
Fasting glucose (mmol/L) 8.07 ± 2.83 8.17 ± 2.83 7.70 ± 2.80 0.01
Fasting insulin (uU/mL) 14.65 ± 18.95 14.98 ± 19.17 12.90 ± 17.66 0.27
HOMA-B 119.37 ± 409.89 124.68 ± 454.9 91.91 ± 168.3 0.41
HOMA-IR 5.28 ± 7.49 5.41 ± 7.90 4.63 ± 5.75 0.30
Postprandial insulin (uU/mL) 62.59 ± 119.61 62.24 ± 112.7 64.46 ± 152.1 0.85
UA (umol/L) 313.5 ± 90.3 312.2 ± 89.6 329.8 ± 92.0 0.02
CRE (umol/L) 63.48 ± 31.26 62.09 ± 37.43 61.34 ± 18.18 0.79
CHO (mmol/L) 4.74 ± 1.19 4.76 ± 1.19 4.59 ± 1.11 0.12
TG (mmol/L) 1.88 ± 1.58 1.96 ± 1.70 1.65 ± 1.01 0.02
HDL-C (mmol/L) 1.17 ± 2.82 1.06 ± 0.41 1.08 ± 0.32 0.42
LDL-C (mmol/L) 2.65 ± 0.84 2.70 ± 0.82 2.68 ± 0.88 0.75
hsCRP (mg/L) 3.0 ± 3.4 3.1 ± 3.0 2.5 ± 3.4 0.09
Urine ALB (mg/g) 84.2 ± 293.1 90.1 ± 305.3 52.8 ± 243.0 0.04